Your browser doesn't support javascript.
loading
Key Characteristics of Cardiovascular Toxicants.
Lind, Lars; Araujo, Jesus A; Barchowsky, Aaron; Belcher, Scott; Berridge, Brian R; Chiamvimonvat, Nipavan; Chiu, Weihsueh A; Cogliano, Vincent J; Elmore, Sarah; Farraj, Aimen K; Gomes, Aldrin V; McHale, Cliona M; Meyer-Tamaki, Kathleen B; Posnack, Nikki Gillum; Vargas, Hugo M; Yang, Xi; Zeise, Lauren; Zhou, Changcheng; Smith, Martyn T.
Afiliación
  • Lind L; Department of Medical Sciences, Clinical Epidemiology, University of Uppsala, Sweden.
  • Araujo JA; Division of Cardiology, David Geffen School of Medicine at University of California Los Angeles (UCLA), UCLA, Los Angeles, California, USA.
  • Barchowsky A; Department of Environmental Health Sciences, Fielding School of Public Health and Molecular Biology Institute, UCLA, Los Angeles, California, USA.
  • Belcher S; Department of Environmental and Occupational Health, Graduate School of Public Health, University of Pittsburgh, Pennsylvania, USA.
  • Berridge BR; Department of Biological Sciences, North Carolina State University, North Carolina, USA.
  • Chiamvimonvat N; Division of the National Toxicology Program, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, North Carolina, USA.
  • Chiu WA; Department of Internal Medicine, University of California, Davis, Davis, California, USA.
  • Cogliano VJ; College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, USA.
  • Elmore S; Office of Environmental Health Hazard Assessment, California Environmental Protection Agency (EPA), Oakland, California, USA.
  • Farraj AK; Office of Environmental Health Hazard Assessment, California Environmental Protection Agency (EPA), Oakland, California, USA.
  • Gomes AV; Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, U.S. EPA, Research Triangle Park, North Carolina, USA.
  • McHale CM; Department of Neurobiology, Physiology and Behavior, College of Biological Sciences, University of California, Davis, Davis, California, USA.
  • Meyer-Tamaki KB; Division of Environmental Health Sciences, School of Public Health, University of California, Berkeley, Berkeley, California, USA.
  • Posnack NG; Sangamo Therapeutics, Brisbane, California, USA.
  • Vargas HM; Children's National Heart Institute and the Sheikh Zayed Institute for Pediatric Surgical Innovation, Children's National Hospital, Washington, DC, USA.
  • Yang X; Translational Safety & Bioanalytical Sciences, Amgen, Inc., Thousand Oaks, California, USA.
  • Zeise L; Division of Pharmacology and Toxicology, Office of Cardiology, Hematology, Endocrinology, and Nephrology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
  • Zhou C; Office of Environmental Health Hazard Assessment, California Environmental Protection Agency (EPA), Oakland, California, USA.
  • Smith MT; Division of Biomedical Sciences, School of Medicine, University of California, Riverside, Riverside, California, USA.
Environ Health Perspect ; 129(9): 95001, 2021 09.
Article en En | MEDLINE | ID: mdl-34558968
BACKGROUND: The concept of chemical agents having properties that confer potential hazard called key characteristics (KCs) was first developed to identify carcinogenic hazards. Identification of KCs of cardiovascular (CV) toxicants could facilitate the systematic assessment of CV hazards and understanding of assay and data gaps associated with current approaches. OBJECTIVES: We sought to develop a consensus-based synthesis of scientific evidence on the KCs of chemical and nonchemical agents known to cause CV toxicity along with methods to measure them. METHODS: An expert working group was convened to discuss mechanisms associated with CV toxicity. RESULTS: The group identified 12 KCs of CV toxicants, defined as exogenous agents that adversely interfere with function of the CV system. The KCs were organized into those primarily affecting cardiac tissue (numbers 1-4 below), the vascular system (5-7), or both (8-12), as follows: 1) impairs regulation of cardiac excitability, 2) impairs cardiac contractility and relaxation, 3) induces cardiomyocyte injury and death, 4) induces proliferation of valve stroma, 5) impacts endothelial and vascular function, 6) alters hemostasis, 7) causes dyslipidemia, 8) impairs mitochondrial function, 9) modifies autonomic nervous system activity, 10) induces oxidative stress, 11) causes inflammation, and 12) alters hormone signaling. DISCUSSION: These 12 KCs can be used to help identify pharmaceuticals and environmental pollutants as CV toxicants, as well as to better understand the mechanistic underpinnings of their toxicity. For example, evidence exists that fine particulate matter [PM ≤2.5µm in aerodynamic diameter (PM2.5)] air pollution, arsenic, anthracycline drugs, and other exogenous chemicals possess one or more of the described KCs. In conclusion, the KCs could be used to identify potential CV toxicants and to define a set of test methods to evaluate CV toxicity in a more comprehensive and standardized manner than current approaches. https://doi.org/10.1289/EHP9321.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Contaminantes Atmosféricos / Contaminación del Aire / Contaminantes Ambientales Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Environ Health Perspect Año: 2021 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Contaminantes Atmosféricos / Contaminación del Aire / Contaminantes Ambientales Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Environ Health Perspect Año: 2021 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Estados Unidos